Insider Selling Broadens Across Mid-Cap Growth and Medical Device Names

The past session produced an unusually broad insider distribution tape. At Kestra Medical Technologies, at least four named officers — the chief financial officer, chief commercial officer, chief business officer and another executive — filed disposals totalling more than $1.9 million, a pattern of near-simultaneous selling that typically signals either coordinated post-lockup liquidity or a shared read on valuation. Larger individual transactions came from Samsara chief executive Sanjit Biswas at $10.1 million, Cactus president Joel Bender at $4.99 million, Curbline Properties director Alexander Otto at $5.2 million and AppFolio director Maurice Duca at $1.6 million. Sea Limited insiders, including a company president who reduced holdings by roughly $4 million, sold into a quarter widely characterised as strong. Insider selling is a notoriously noisy signal in isolation — diversification, tax planning and scheduled 10b5-1 programmes explain most activity. The relevant observation here is breadth: clustered, multi-officer selling across growth software, energy services, real estate and medical devices during a period of elevated index valuations is consistent with management teams treating current prices as a favourable exit rather than an entry.